Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients

Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) can induce long-term remissions in patients with chronic lymphocytic leukemia. Treatment efficacy with Bruton's tyrosine kinase inhibitors was found similar to FCR in untreated chronic lymphocytic leukemia patients with a mut...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Johannes Bloehdorn, Julia Krzykalla, Karlheinz Holzmann, Andreas Gerhardinger, Billy Michael Chelliah Jebaraj, Jasmin Bahlo, Kathryn Humphrey, Eugen Tausch, Sandra Robrecht, Daniel Mertens, Christof Schneider, Kirsten Fischer, Michael Hallek, Hartmut Döhner, Axel Benner, Stephan Stilgenbauer
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Ferrata Storti Foundation 2021-03-01
Sarja:	Haematologica
Linkit:	https://haematologica.org/article/view/10209
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!